A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) with or without Cetuximab (C225) after Curative Resection for Patients with Stage III Colon Cancer

Association of Adiponectin with Tumor Infiltrating Lymphocytes in Patients with Stage III Colon Cancer Treated in an Adjuvant Chemotherapy Trial (NCCTG N0147, Alliance)

F Sinicrope;Q Shi;T Smyrk;R Goldberg;E Heying;S Cohen;S Gill;D Sha;Z Jin;M Kahlenberg;S Nair;A Shields;B Jahagirdar;N Foster;M Pollak;S Alberts J Clin Oncol 39, 2021 (suppl 15; abstr 3591) (American Society of Clinical Oncology Annual Meeting 2021, poster session)

Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer

F Sinicrope;Q Shi;F Hermitte;T Zemla;B Mlecnik;A Benson;S Gill;RM Goldberg;M Kahlenberg;S Nair;AF Shields;T Smyrk;J Galon;S Alberts JNCI Cancer Spectrum Apr 5;4(3):pkaa023. doi: 10.1093/jncics/pkaa023. eCollection 2020 Jun.

PMid: PMID32455336 | PMC number: PMC7236783

Physical Activity and Outcomes in Patients with Stage III Colon Cancer: A Correlative Analysis of Phase III Trial NCCTG N0147 (Alliance)

AI Phipps;X Shi;T Zemla;E Dotan;S Gill;RM Goldberg;S Hardikar;B Jahagirdar;PJ Limburg;P Newcomb;A Shields;FA Sinicrope;DJ Sargent;SR Alberts Cancer Epidemiology, Biomarkers, Prevention Jun;27(6):696-703

PMid: PMID29563133 | PMC number: PMC5984710

Association of micropapillary architecture and high tumor budding with prognosis in patients with stage III colon cancer from a FOLFOX-based adjuvant chemotherapy Trial: NCCTG N0147 (Alliance)

HE Lee;Q Shi;N Foster;DJ Sargent;E Chan;S Gill;M Kahlenberg;S Nair;AF Shields;RM Goldberg;SR Alberts;FA Sinicrope;TC Smyrk Mod Pathol 2017;30(S2):181A; USCAP 2017 Meeting (March 4-10, 2017, San Antonio, TX), poster

Pre-diagnostic physical activity and outcomes in patients with stage III colon cancer: A correlative analysis of phase III trial NCCTG N0147 (Alliance)

A Phipps;Q Shi;E Chan;S Gill;RM Goldberg;S Hardikar;PJ Limburg;PA Newcomb;A Shields;F Sinicrope;TJ Zemla;DJ Sargent;SR Alberts American Society of Preventive Oncology Annual Meeting (March 11-14, 2017, Seattle, Washington), poster

Analysis of serum vitamin D levels and prognosis in stage III colon carcinoma patients treated with adjuvant FOLFOX+/- cetuximab chemotherapy: NCCTG N0147 (Alliance)

F Sinicrope;Q Shi;T Smyrk;R Goldberg;W Heying;E Chan;S Gill;M Kahlenberg;S Nair;A Shields;D Sargent;M Pollak;S Alberts J Clin Oncol 35, 2017 (suppl; abstr 3516); American Society of Clinical Oncology Annual Meeting (June 2-6, 2017, Chicago, IL), poster discussion

Association of immune markers and immunoscore with survival of stage III colon cancer (CC) patients treated with adjuvant FOLFOX: NCCTG N0147 (Alliance)

F Sinicrope;Q Shi;F Hermitte;E Heying;E Chan;S Gill;R Goldberg;M Kahlenberg;S Nair;A Shields;D Sargent;J Galon;S Alberts J Clin Oncol 35, 2017 (suppl; abstr 3579); American Society of Clinical Oncology Annual Meeting (June 2-6, 2017, Chicago, IL), poster session

Genetic correlates of therapeutic toxicities of stage III colon cancer patients treated with adjuvant FOLFOX+/-cetuximab (NCCTG N0147, Alliance)

P Newcomb;M Sun;X Hua;B Banbury;A Phipps;J Kocarnik;T Harrison;Q Shi;F Sinicrope;S Thidbodeau;E Chan;S Gill;R Goldberg;M Kahlenberg;S Nair;A Shields;U Peters;S Alberts;AT Chan J Clin Oncol 35, 2017 (suppl; abstr 3604); American Society of Clinical Oncology Annual Meeting (June 2-6, 2017, Chicago, IL), poster session

Evaluation of immunoscore and immune biomarkers in stage III colon carcinoma patients treated with adjuvant FOLFOX in a phase III trial (NCCTG N0147; Alliance)

F Sinicrope;Q Shi;F Hermitte;E Heying;A Benson;S Gill;R Goldberg;MS Kahlenberg;S Nair;A Shields;S Sargent;J Galon;S Alberts Annals of Oncology Jun 1;28(suppl_3) LBA

Alcohol consumption and colon cancer prognosis among participants in North Central Cancer Treatment Group phase III trial N0147

A Phipps;Q Shi;P Limburg;GD Nelson;DJ Sargent;F Sinicrope;E Chan;S Gill;RM Goldberg;M Kahlenberg;S Nair;A Shields;PA Newcomb;SR Alberts International Journal of Cancer, Sep 1;139(5):986-995; 2016 Apr 8 [Epub ahead of print]

PMid: PMID27060850 | PMC number: PMC4911257

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)

AM Lee;Q Shi Qian;SR Alberts;DJ Sargent;FA Sinicrope;JL Berenberg;A Grothey;B Polite;E Chan;S Gill;MS Kahlenberg;SG Nair;AF Shields;RM Goldberg;RB Diasio Pharmacogenetics and Genomics, Mar;26(3):133-137

PMid: PMID26658227 | PMC number: PMC4738010

Relationship between metformin use and recurrence and survival in patients with resected stage III colon cancer receiving adjuvant chemotherapy: results from North Central Cancer Treatment Group N0147 (Alliance)

P Singh;Q Shi;N Foster;A Grothey;S Nair;E Chane;A Shields;R Goldberg;S Gill;M Kahlenberg;F Sinicrope;D Sargent;S Alberts Oncologist Dec;21(12):1509-1521; Epub 2016 Nov 23

PMid: PMID27881709 | PMC number: PMC5153338

Relationship between metformin use and recurrence and survival in patients (pts) with resected stage III colon cancer (CC) Receiving Adjuvant Chemotherapy: Results from NCCTG N0147 (Alliance).

PP Singh;Q Shi;N Foster;A Grothey;A Shields;FA Sinicrope;DJ Sargent;SR Alberts Journal of Clinical Oncology 33:5s (suppl; abstr 3531); American Society of Clinical Oncology Annual Meeting (May 29-June 2,2015, Chicago, IL), poster session;

Alcohol consumption and prognosis in patients with stage III colon cancer: A correlative analysis of phase III trial NCCTG N0147 (Alliance)

A Phipps;Q Shi;P Limburg;GD Nelson;DJ Sargent;F Sinicrope;E Chan;S Gill;RM Goldberg;M Kahlenberg;S Nair;AF Shields;PA Newcomb;SR Alberts Journal of Clinical Oncology 33:5s (suppl; abstr 1508); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), oral presentation;

Comparison of FOLFIRI With or Without Cetuximab in Patients With Resected Stage III Colon Cancer; NCCTG (Alliance) Intergroup Trial N0147

J Huang;SG Nair;MR Mahoney;GD Nelson;AF Shields;E Chan;RM Goldberg;S Gill;MS Kahlenberg;JT Quesenberry;SN Thibodeau;TC Smyrk;A Grothey;FA Sinicrope;TA Webb;GH Farr;BA Pockaj;JL Berenberg;M Mooney;DJ Sargent;SR Alberts Clinical Colorectal Cancer 13(2):100-109;

PMid: PMID24512953 | PMC number: PMC4019685

Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer

SR Alberts;DJ Sargent;S Nair;M Mahoney;M Mooney;SN Thibodeau;TC Smyrk;FA Sinicrope;E Chan;S Gill;MS Kahlenberg;AF Shields;JT Quesenberry;TA Webb;GH Farr, Jr;BA Pockaj;A Grothey;RM Goldberg Journal of the American Medical Association 307(13):1383-1393

PMid: PMID22474202 | PMC number: PMC3442260